Baschat AA, Gembruch U, Harman CR The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens. Ultrasound Obstet Gynecol. 2001 Dec;18(6):571-7.
Baschat AA Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound Obstet Gynecol. 2011 May;37(5):501-14. doi: 10.1002/uog.9008. Review.
Caradeux J, Martinez-Portilla RJ, Basuki TR, Kiserud T, Figueras F Risk of fetal death in growth-restricted fetuses with umbilical and/or ductus venosus absent or reversed end-diastolic velocities before 34 weeks of gestation: a systematic review and meta-analysis. Am J Obstet Gynecol. 2018 Feb;218(2S):S774-S782.e21. doi: 10.1016/j.ajog.2017.11.566. Epub 2017 Dec 9.
Crimmins S, Desai A, Block-Abraham D, Berg C, Gembruch U, Baschat AA A comparison of Doppler and biophysical findings between liveborn and stillborn growth-restricted fetuses. Am J Obstet Gynecol. 2014 Dec;211(6):669.e1-10. doi: 10.1016/j.ajog.2014.06.022. Epub 2014 Jun 12.
McCowan LM, Harding J, Roberts A, Barker S, Ford C, Stewart A Administration of low-dose aspirin to mothers with small for gestational age fetuses and abnormal umbilical Doppler studies to increase birthweight: a randomised double-blind controlled trial. Br J Obstet Gynaecol. 1999 Jul;106(7):647-51.
Morrow RJ, Adamson SL, Bull SB, Ritchie JW Effect of placental embolization on the umbilical arterial velocity waveform in fetal sheep. Am J Obstet Gynecol. 1989 Oct;161(4):1055-60.
Ohshige A, Yoshimura T, Maeda T, Ito M, Okamura H Increased platelet-activating factor-acetylhydrolase activity in the umbilical venous plasma of growth-restricted fetuses. Obstet Gynecol. 1999 Feb;93(2):180-3.
Pardey J, Moulden M, Redman CW A computer system for the numerical analysis of nonstress tests. Am J Obstet Gynecol. 2002 May;186(5):1095-103. Review.
Parker CR Jr, Hauth JC, Goldenberg RL, Cooper RL, Dubard MB Umbilical cord serum levels of thromboxane B2 in term infants of women who participated in a placebo-controlled trial of low-dose aspirin. J Matern Fetal Med. 2000 Jul-Aug;9(4):209-15.
Redline RW, Ravishankar S Fetal vascular malperfusion, an update. APMIS. 2018 Jul;126(7):561-569. doi: 10.1111/apm.12849. Review.
Trudinger B, Song JZ, Wu ZH, Wang J Placental insufficiency is characterized by platelet activation in the fetus. Obstet Gynecol. 2003 May;101(5 Pt 1):975-81.
Wilcox GR, Trudinger BJ Fetal platelet consumption: a feature of placental insufficiency. Obstet Gynecol. 1991 Apr;77(4):616-21.
Ylikorkala O, Mäkilä UM, Kääpä P, Viinikka L Maternal ingestion of acetylsalicylic acid inhibits fetal and neonatal prostacyclin and thromboxane in humans. Am J Obstet Gynecol. 1986 Aug;155(2):345-9.
A Randomized Trial of Transplacental Aspirin Therapy for Early Onset Fetal Growth
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.